Celgene Corporate Counsel, Manufacturing in Summit, New Jersey
Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, quest for innovation, spirit of independence and love of challenge. With a presence in more than 70 countries, and growing - we look for talented people to grow our business, advance our science and contribute to our unique culture.
Under the direction of the Senior Corporate Counsel of the contracts/transactional sub-group in the legal department, the Corporate Counsel will provide legal support to the global pharmaceutical development (“GPDO”) group with responsibility for counseling on a broad range of legal issues related to manufacturing and supply of pharmaceutical products, gene therapies and biologics. These responsibilities include: (1) drafting manufacturing and supply agreements and supporting negotiations of those agreements; (2) counseling on compliance with good manufacturing practices, inspection readiness and responses, and other compliance issues related to manufacturing and supply; and (3) and advising on U.S. import/export issues that impact manufacturing and supply. The Corporate Counsel will provide strategic advice and counsel and be closely involved with the manufacturing business, leveraging in-depth knowledge of manufacturing and supply. In addition, the Corporate Counsel will be called upon to support GPDO in strategic transactions, such as acquisitions, collaborations and licenses. High volume of contracts requires the ability to meet tight deadlines. Must have strong interpersonal skills, be a team player and be willing to work in an environment where individual initiative and accountability to the team are required.
Minimum Skills/Knowledge Required:
Candidate should have 5-10 years of experience, must have a J.D. and be admitted to at least one state Bar, New Jersey or New York Bar preferred.
At least five years of experience as an attorney in transactional law with either a law firm or corporation in the pharmaceutical, chemical or biological sciences industry with focus on manufacturing agreements, supply agreements, quality agreements, lab services agreements and other related contractual arrangements, including relating to API, drug product, drug substance, packaging and labeling and finished goods manufacturing and supply. Experience with manufacturing and supply regulatory and compliance issues is a plus.
Candidates must have strong contract negotiation and drafting skills and proven ability to develop and implement legal strategies that support business and financial objectives.
Ability to prioritize and multi-task, processing multiple transactions to satisfactory completion.
Ability to work cross functionally with multiple stakeholders from various departments including manufacturing, technical operations, finance and alliance management.
Ability to appropriately balance legal and business risks while complying with short turnaround cycles and setting client expectations.
Attention to detail.
Excellent communication skills (verbal and written).
History of self-motivation, sound judgment and excellent interpersonal relations.
Must be able to work with minimal supervision.
Celgene is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Celgene complies with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Celgene in the U.S.COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE
At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
“At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients.”
There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.